Renaissance BioScience Corp., a global leader in bioengineered yeast, announced that the Mexican patent office has granted a patent for its innovative yeast-based platform technology that enables low-cost production and effective delivery of RNA. This is the third patent issued for the company's RNA technology, following earlier grants in China and Australia, with additional patent applications pending in other jurisdictions. The new patent strengthens Renaissance's robust intellectual property portfolio of issued and pending patents for yeast-based technologies across multiple end-use markets.
The company's most advanced commercial application of this RNA production and delivery system is a suite of RNAi-based biopesticide products. These products provide precise, targeted pest control and offer a strong environmental safety profile compared with broad-spectrum chemical pesticides, while maintaining competitive production costs at scale. Importantly, the technology integrates smoothly into current farming practices and equipment.
Dr. John Husnik, Renaissance's CSO and Office of the CEO, commented on the new patent: "This patent from the Mexican office confirms the novelty and importance of our yeast-based RNA technology for producing, protecting and delivering next-generation RNA bioactive molecules. In addition to biopesticides, this platform offers exciting opportunities across a wide range of multi-billion-dollar commercial markets."
The patent grant underscores Renaissance's commitment to developing innovative solutions that address environmental and industrial challenges. The company's yeast bioengineering capabilities are being applied in agriculture, animal and human health, food, energy, and more. For more information about Renaissance BioScience and its technologies, visit www.renaissancebioscience.com.
